IRIS
CONFORTI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 282
EU - Europa 62
SA - Sud America 53
NA - Nord America 48
AF - Africa 15
Totale 460
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 90
CN - Cina 66
VN - Vietnam 45
BR - Brasile 36
US - Stati Uniti d'America 36
IN - India 18
FR - Francia 16
IT - Italia 10
PH - Filippine 9
ID - Indonesia 8
MX - Messico 8
BD - Bangladesh 6
IQ - Iraq 6
MA - Marocco 6
RU - Federazione Russa 6
AR - Argentina 5
ES - Italia 5
HK - Hong Kong 5
SA - Arabia Saudita 5
EG - Egitto 4
DE - Germania 3
EC - Ecuador 3
GB - Regno Unito 3
JP - Giappone 3
KH - Cambogia 3
MY - Malesia 3
PK - Pakistan 3
QA - Qatar 3
TR - Turchia 3
AL - Albania 2
BY - Bielorussia 2
CA - Canada 2
PE - Perù 2
RS - Serbia 2
UA - Ucraina 2
UY - Uruguay 2
AO - Angola 1
AT - Austria 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
FI - Finlandia 1
GM - Gambi 1
GR - Grecia 1
HR - Croazia 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
NL - Olanda 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 460
Salva come PNG Salva come JPEG
Città #
Ho Chi Minh City 17
Singapore 17
Beijing 13
Hanoi 11
Hillsboro 5
Hong Kong 5
New York 5
São Paulo 5
Baghdad 4
Casablanca 4
Ashburn 3
Cairo 3
Da Nang 3
Doha 3
Paris 3
Phnom Penh 3
Acapulco de Juárez 2
Assago 2
Belgrade 2
Dammam 2
Jeddah 2
Kolkata 2
Manila 2
Milan 2
Montevideo 2
Mérida 2
Quito 2
Rio de Janeiro 2
San Jose 2
Santa Clara 2
Abbottabad 1
Acreúna 1
Agadir 1
Agra 1
Amman 1
Anand 1
Ancol 1
Angeles City 1
Arecibo 1
Athens 1
Bandeira do Sul 1
Barquisimeto 1
Barranda 1
Basra 1
Bauru 1
Belo Horizonte 1
Berrechid 1
Blagoevgrad 1
Boulder 1
Brasília 1
Bremen 1
Brikama 1
Brooklyn 1
Buffalo 1
Burzaco 1
Bình Dương 1
Bắc Giang 1
Camboriú 1
Can Tho 1
Capitão de Campos 1
Castel Sant'Elia 1
Caxias do Sul 1
Charlotte 1
Chelmsford 1
Chiclín 1
Chāndpur 1
City of London 1
Copenhagen 1
Corunna 1
Cuauhtémoc 1
Cuenca 1
Curitiba 1
Dallas 1
Dau 1
Delray Beach 1
Denizli 1
Depok 1
Dhaka 1
Ecatepec 1
Elbasan 1
Encarnación 1
Ensenada 1
Erbil 1
Fier 1
Forquilhinha 1
Fortaleza 1
Francisco Morato 1
Frankfurt am Main 1
Giza 1
Go Vap 1
Goioerê 1
Helsinki 1
Hải Dương 1
Iloilo City 1
Ingenio 1
Ipoh 1
Istanbul 1
Jacareí 1
Jaipur 1
Jakarta 1
Totale 202
Salva come PNG Salva come JPEG
Nome #
The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME) 42
Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinoma 21
Correlation between treatments and outcomes of patients with EGFR-mutated non-small-cell lung cancer that transitioned into small-cell lung cancer: an international retrospective study 13
Bridging Knowledge Gaps in Small Cell Lung Cancer: Data, Challenges and Priorities 13
Aprepitant use during chemotherapy and association with survival in women with early breast cancer 12
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 11
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy 11
“Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.” 10
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 9
Dasatinib sensitises KRAS-mutant cancer cells to mitogen-activated protein kinase kinase inhibitor via inhibition of TAZ activity 9
Sex-based differences of the tumor mutational burden and T-cell inflammation of the tumor microenvironment 9
Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer Critical Analysis of Strengths, Weaknesses, and Misinterpretations 8
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis 8
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis 8
Comparison of filgrastim and pegfilgrastim prophylaxis in sarcoma patients receiving highly myelosuppressive chemotherapy 7
Molecular and clinical features of second-generation anaplastic lymphoma kinase inhibitors ceritinib 7
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations 7
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 7
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy 7
Primary ipilimumab/nivolumab followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome 7
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy 7
A phase II study of regorafenib in patients with thymic epithelial tumours previously treated with chemotherapy 7
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML 7
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung 7
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study 7
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to action 7
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study 6
Sex and cancer immunotherapy: Current understanding and challenges 6
Xpo1 Inhibition: A Promising Therapeutic Strategy in Thymic Epithelial Tumors 6
Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome 6
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy 6
Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E 6
Thymic epithelial tumors: From biology to treatment 6
Boosting anticancer immunotherapy through androgen receptor blockade 6
Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and Immunotherapy 6
Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator? 6
Extensive vitiligo associated to response to c-kit inhibitor in metastatic mucosal melanoma 6
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials 6
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials 6
Different Response to Immunotherapy According to Melanoma Histologic Subtype 6
Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials A Systematic Review and Meta-analysis 6
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center 6
Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors 6
Editorial: Differential Efficacy of Immune Checkpoint Inhibitors due to Age and Sex Factors 6
Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trials 6
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial 6
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis 6
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 5
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis 5
EPIDERMAL GROWTH FACTORS TYROSINE-KINASE INHIBITORS (EGFR-TKI) EFFICACY IN NSCLC PATIENTS WITH HIGH POLYSOMY OF CHROMOSOME 7 AND EGFR/KRAS WILD TYPE TUMORS 5
Sex as a predictor of response to cancer immunotherapy Reply 5
Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors 5
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 5
Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma 5
Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome 5
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis 5
Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling 5
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature 5
Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors 5
Sex-based differences of the intratumoral immune-infiltrate 5
Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practice 5
The effect of patient sex on the efficacy and safety of anticancer immunotherapy 5
EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical Trials 5
Targeting ALK in patients with advanced Non Small Cell Lung Cancer: Biology, diagnostic and therapeutic options 5
Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis 5
Successful treatment with avapritinib in patient with mucosal metastatic melanoma 5
Sex-based dimorphism in the SARS-CoV2 virulence 4
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers 4
Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer 4
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence 4
Original Research Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy 4
PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors 4
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review 4
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review 4
Biological and clinical features of early triple-negative invasive lobular carcinomas of the breast 4
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis 3
Erlotinib Efficacy in NSCLC Patients with High Polysomy of Chromosome 7 and EGFR/KRas Wild-Type Tumors 3
Metaplastic breast cancer: Prognostic and therapeutic considerations 3
Molecular features and clinical outcome of lung malignancies in very young people 3
Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature 3
Totale 540
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.642
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202519 0 0 0 0 0 0 0 0 0 0 8 11
2025/2026521 2 1 3 10 6 9 13 303 119 55 0 0
Totale 540